Diabetic kidney disease: Are the reported associations with single-nucleotide polymorphisms disease-specific?

Chronic kidney disease Diabetes mellitus Diabetic kidney disease End-stage kidney disease Single-nucleotide polymorphism

Journal

World journal of diabetes
ISSN: 1948-9358
Titre abrégé: World J Diabetes
Pays: United States
ID NLM: 101547524

Informations de publication

Date de publication:
15 Oct 2021
Historique:
received: 16 03 2021
revised: 26 05 2021
accepted: 07 09 2021
entrez: 10 11 2021
pubmed: 11 11 2021
medline: 11 11 2021
Statut: ppublish

Résumé

The genetic backgrounds of diabetic kidney disease (DKD) and end-stage kidney disease (ESKD) have not been fully elucidated. To examine the individual and cumulative effects of single-nucleotide polymorphisms (SNPs) previously associated with DKD on the risk for ESKD of diabetic etiology and to determine if any associations observed were specific for DKD. Fourteen SNPs were genotyped in hemodialyzed 136 patients with diabetic ESKD (DKD group) and 121 patients with non-diabetic ESKD (NDKD group). Patients were also re-classified on the basis of the primary cause of chronic kidney disease (CKD). The distribution of alleles was compared between diabetic and non-diabetic groups as well as between different sub-phenotypes. The weighted multilocus genetic risk score (GRS) was calculated to estimate the cumulative risk conferred by all SNPs. The GRS distribution was then compared between the DKD and NDKD groups as well as in the groups according to the primary cause of CKD. One SNP (rs841853; SLC2A1) showed a nominal association with DKD ( Our results suggest that selected SNPs that were previously associated with DKD may not be specific for DKD and may confer risk for CKD of different etiology, particularly those affecting renal glomeruli.

Sections du résumé

BACKGROUND BACKGROUND
The genetic backgrounds of diabetic kidney disease (DKD) and end-stage kidney disease (ESKD) have not been fully elucidated.
AIM OBJECTIVE
To examine the individual and cumulative effects of single-nucleotide polymorphisms (SNPs) previously associated with DKD on the risk for ESKD of diabetic etiology and to determine if any associations observed were specific for DKD.
METHODS METHODS
Fourteen SNPs were genotyped in hemodialyzed 136 patients with diabetic ESKD (DKD group) and 121 patients with non-diabetic ESKD (NDKD group). Patients were also re-classified on the basis of the primary cause of chronic kidney disease (CKD). The distribution of alleles was compared between diabetic and non-diabetic groups as well as between different sub-phenotypes. The weighted multilocus genetic risk score (GRS) was calculated to estimate the cumulative risk conferred by all SNPs. The GRS distribution was then compared between the DKD and NDKD groups as well as in the groups according to the primary cause of CKD.
RESULTS RESULTS
One SNP (rs841853; SLC2A1) showed a nominal association with DKD (
CONCLUSION CONCLUSIONS
Our results suggest that selected SNPs that were previously associated with DKD may not be specific for DKD and may confer risk for CKD of different etiology, particularly those affecting renal glomeruli.

Identifiants

pubmed: 34754377
doi: 10.4239/wjd.v12.i10.1765
pmc: PMC8554375
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1765-1777

Informations de copyright

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare that they have no competing financial interests. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

Références

PLoS Genet. 2012 Sep;8(9):e1002921
pubmed: 23028342
Diabetologia. 2011 Apr;54(4):803-11
pubmed: 21181397
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Clin J Am Soc Nephrol. 2007 Nov;2(6):1306-16
pubmed: 17942768
Sci Rep. 2018 Aug 17;8(1):12408
pubmed: 30120300
Metabolism. 2015 Jun;64(6):713-9
pubmed: 25804128
Med Clin North Am. 2013 Jan;97(1):1-18
pubmed: 23290726
Diabetologia. 2011 Mar;54(3):544-53
pubmed: 21127830
Diabetes. 2009 Jul;58(7):1651-8
pubmed: 19401416
Pharmacol Ther. 2010 Oct;128(1):61-81
pubmed: 20600306
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
J Diabetes. 2015 Jan;7(1):31-40
pubmed: 24825737
Diabetes. 2015 Dec;64(12):4238-46
pubmed: 26307587
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):87-109
pubmed: 26676663
Int J Nephrol. 2019 Aug 22;2019:1095215
pubmed: 31534799
BMC Nephrol. 2018 Oct 30;19(1):301
pubmed: 30376835
Kidney Int. 2011 Jul;80(1):105-11
pubmed: 21412220
J Am Soc Nephrol. 2019 Oct;30(10):2000-2016
pubmed: 31537649
Nat Genet. 2019 Jun;51(6):957-972
pubmed: 31152163
Ren Fail. 2015;37(8):1247-59
pubmed: 26161693
Clin Exp Nephrol. 2013 Dec;17(6):866-71
pubmed: 23543049
Sci Rep. 2018 Jun 18;8(1):9284
pubmed: 29915175
Nat Commun. 2019 Aug 26;10(1):3842
pubmed: 31451708
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
BMC Med Genet. 2014 Oct 04;15:103
pubmed: 25280384
Mol Biol Rep. 2012 Aug;39(8):8551-8
pubmed: 22707195
Curr Opin Genet Dev. 2018 Jun;50:17-24
pubmed: 29453109
Nat Commun. 2019 Jan 3;10(1):29
pubmed: 30604766
Rheumatol Int. 2019 Feb;39(2):327-336
pubmed: 30374689
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045
pubmed: 28522654
World J Transplant. 2016 Sep 24;6(3):556-63
pubmed: 27683634
Diabetologia. 2013 Feb;56(2):323-9
pubmed: 23111731
Front Genet. 2019 May 24;10:494
pubmed: 31178898
Am J Nephrol. 2010;32(5):476-81
pubmed: 20962522
Diabetes. 2007 Apr;56(4):975-83
pubmed: 17395743
Pol Arch Intern Med. 2019 Dec 23;129(12):864-873
pubmed: 31596271
Mol Biol Rep. 2012 Feb;39(2):1293-303
pubmed: 21607620
Front Genet. 2019 Apr 16;10:330
pubmed: 31040861
Nat Commun. 2016 Jan 21;7:10023
pubmed: 26831199
PLoS One. 2017 Jun 15;12(6):e0179348
pubmed: 28617847
Nephrol Dial Transplant. 2012 Jan;27(1):190-6
pubmed: 21765051
Front Genet. 2019 Jun 07;10:507
pubmed: 31231424
Int Urol Nephrol. 2015 Jan;47(1):117-30
pubmed: 25262148
J Am Soc Nephrol. 2020 Feb;31(2):309-323
pubmed: 31919106
Endocrine. 2011 Dec;40(3):372-8
pubmed: 21725704
Diabetes Metab. 2019 Oct;45(5):494-497
pubmed: 29540294

Auteurs

Marek Saracyn (M)

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw 04-141, Poland.

Bartłomiej Kisiel (B)

Clinical Research Support Center, Military Institute of Medicine, Warsaw 04-141, Poland.

Maria Franaszczyk (M)

Department of Medical Biology, Molecular Biology Laboratory, Institute of Cardiology, Warsaw 04-628, Poland.

Dorota Brodowska-Kania (D)

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw 04-141, Poland.

Wawrzyniec Żmudzki (W)

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw 04-141, Poland.

Robert Małecki (R)

Department of Nephrology, Międzyleski Specialist Hospital in Warsaw, Warsaw 04-749, Poland.

Longin Niemczyk (L)

Department of Nephrology, Dialysis and Internal Diseases, Warsaw Medical University, Warsaw 02-097, Poland.

Przemysław Dyrla (P)

Department of Gastroenterology, Military Institute of Medicine, Warsaw 04-141, Poland.

Grzegorz Kamiński (G)

Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw 04-141, Poland.

Rafał Płoski (R)

Department of Medical Genetics, Medical University of Warsaw, Warsaw 02-106, Poland.

Stanisław Niemczyk (S)

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw 04-141, Poland.

Classifications MeSH